These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 8545466

  • 1. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M, Yamada K, Nagashima M, Shirakawa K, Furukawa T.
    Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of putative dopamine D3 receptor agonists, 7-OH-DPAT and quinpirole, on prolactin secretion in rats.
    Kurashima M, Domae M, Inoue T, Nagashima M, Yamada K, Shirakawa K, Furukawa T.
    Pharmacol Biochem Behav; 1996 Feb; 53(2):379-83. PubMed ID: 8808147
    [Abstract] [Full Text] [Related]

  • 3. 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.
    Oswiecimska J, Brus R, Szkilnik R, Nowak P, Kostrzewa RM.
    Pharmacol Biochem Behav; 2000 Sep; 67(1):11-5. PubMed ID: 11113478
    [Abstract] [Full Text] [Related]

  • 4. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
    Dall'Olio R, Gaggi R, Voltattorni M, Tanda O, Gandolfi O.
    Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
    [Abstract] [Full Text] [Related]

  • 5. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [Abstract] [Full Text] [Related]

  • 6. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293
    [Abstract] [Full Text] [Related]

  • 7. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD, Rodefer JS, Picker MJ.
    Psychopharmacology (Berl); 1999 Jun 25; 144(3):239-47. PubMed ID: 10435390
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
    Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T.
    Psychopharmacology (Berl); 1990 Jun 25; 100(2):141-4. PubMed ID: 1968276
    [Abstract] [Full Text] [Related]

  • 9. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1996 Apr 25; 124(3):231-40. PubMed ID: 8740044
    [Abstract] [Full Text] [Related]

  • 10. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 24; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 12. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar 24; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 13. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH, Ellerbrock BR, Fici GJ, Wu H.
    Brain Res; 1996 Sep 09; 733(1):41-5. PubMed ID: 8891246
    [Abstract] [Full Text] [Related]

  • 14. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats.
    Van den Buuse M.
    Eur J Pharmacol; 1993 Oct 19; 243(2):169-77. PubMed ID: 8276066
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic modulation of rat pup ultrasonic vocalizations.
    Dastur FN, McGregor IS, Brown RE.
    Eur J Pharmacol; 1999 Oct 08; 382(2):53-67. PubMed ID: 10528139
    [Abstract] [Full Text] [Related]

  • 16. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L, Longoni R, Mulas A, Di Chiara G.
    Psychopharmacology (Berl); 1989 Oct 08; 98(4):567-8. PubMed ID: 2570436
    [Abstract] [Full Text] [Related]

  • 17. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL, Alling KL.
    Behav Pharmacol; 2000 Sep 08; 11(6):483-93. PubMed ID: 11103914
    [Abstract] [Full Text] [Related]

  • 18. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C, Biala G, Le Bihan C, Hamon M, Thiébot MH.
    Psychopharmacology (Berl); 2003 Feb 08; 166(1):19-32. PubMed ID: 12525958
    [Abstract] [Full Text] [Related]

  • 19. Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
    Uzbay IT, Kayir H.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr 08; 367(4):414-21. PubMed ID: 12690434
    [Abstract] [Full Text] [Related]

  • 20. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.
    Fujikawa M, Nagashima M, Inoue T, Yamada K, Furukawa T.
    Pharmacol Biochem Behav; 1996 Apr 08; 53(4):903-9. PubMed ID: 8801596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.